AOP Orphan announces launch of access program for EGRIFTA®

AOP Orphan announces launch of access program for the world’s first drug against lipodystrophy in HIV patients, EGRIFTA®, in Europe
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: *** Editor's Pick Clinical trials Practical therapeutics Specials and orphan drugs Patient care Research access program cardiovascular disease EGRIFTA GHRH hiv Latest News lipids lipodystrophy metabolic changes Tesamorelin Source Type: news